Latin America Newborn Screening Market Size & Outlook
The newborn screening market in Latin America is expected to reach a projected revenue of US$ 169.8 million by 2033. A compound annual growth rate of 7% is expected of Latin America newborn screening market from 2026 to 2033.
The Latin America newborn screening market generated a revenue of USD 99.6 million in 2025.
The market is expected to grow at a CAGR of 7% from 2026 to 2033.
In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2025.
Tandem Mass Spectrometry is the most lucrative technology segment registering the fastest growth during the forecast period.
Country-wise, Argentina is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
Market revenue in 2025
USD 99.6 million
Market revenue in 2033
USD 169.8 million
Growth rate
7% (CAGR from 2026 to 2033)
Largest segment
Tandem mass spectrometry
Fastest growing segment
Tandem Mass Spectrometry
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Tandem Mass Spectrometry, Electrophoresis, Pulse Oximetry, Enzyme-based Assay, DNA Assays
Key market players worldwide
Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp
Other key industry trends
In terms of revenue, Latin America region accounted for 10.3% of the global newborn screening market in 2025.
Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 630.2 million by 2033.
The coverage rate for screening in newborn varies across the 20 countries of Latin America. 100% coverage is observed in Chile, Cuba, and Uruguay, and countries such as El Salvador, Haiti, and Honduras have negligible coverage. Congenital hypothyroidism testing is mandated in ten countries, whereas phenylketonuria testing is compulsory only in Costa Rica, Paraguay, Brazil, Venezuela, Guatemala, and Chile.
However, parents can demand for additional testing depending on the need. Recently, emphasis on cystic fibrosis and hearing screen has gained momentum across the region. In 2012, World Solutions Against Infectious Diseases (WSAID) announced partnership with Save Babies Through Screening Foundation (SBTS) and work for expansion of the screening program with the region.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Newborn Screening Market Outlook will help companies and investors design strategic landscapes.
Tandem Mass Spectrometry was the largest segment with a revenue share of 26.51% in 2025.
Horizon Databook has segmented the Latin America newborn screening market based on tandem mass spectrometry, electrophoresis, pulse oximetry, enzyme-based assay, dna assays covering the revenue growth of each sub-segment from 2021 to 2033.
The coverage rate for screening in newborn varies across the 20 countries of Latin America. 100% coverage is observed in Chile, Cuba, and Uruguay, and countries such as El Salvador, Haiti, and Honduras have negligible coverage. Congenital hypothyroidism testing is mandated in ten countries, whereas phenylketonuria testing is compulsory only in Costa Rica, Paraguay, Brazil, Venezuela, Guatemala, and Chile.
However, parents can demand for additional testing depending on the need. Recently, emphasis on cystic fibrosis and hearing screen has gained momentum across the region. In 2012, World Solutions Against Infectious Diseases (WSAID) announced partnership with Save Babies Through Screening Foundation (SBTS) and work for expansion of the screening program with the region.
Latin America Newborn Screening Market Technology Outlook (Revenue, USD Million , 2021-2033)
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme-based Assay
DNA Assays
Electrophoresis
Others
Latin America Newborn Screening Market Test Type Outlook (Revenue, USD Million , 2021-2033)
Dry Blood Spot Test
CCHD
Hearing Screen
Latin America Newborn Screening Market Product Outlook (Revenue, USD Million , 2021-2033)
Instruments
Reagents
Reasons to subscribe to Newborn Screening Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Newborn Screening Market Outlook databook
Our clientele includes a mix of Newborn Screening Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Newborn Screening Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Newborn Screening Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Latin America Newborn Screening Market, 2021-2033 (US$M)